PD 180970

Discontinued Product

4965 has been discontinued.

View all Abl Kinase products.
说明: p210Bcr/Abl kinase inhibitor; also inhibits c-Src and KIT
化学名: 6-(2,6-Dichlorophenyl)-2-[(4-fluoro-3-methylphenyl)amino]-8-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one
纯度: ≥98% (HPLC)
说明书
引用文献 (1)
评论

生物活性 for PD 180970

PD 180970 is an ATP-competitive inhibitor of p210bcr/abl tyrosine kinase; selectively induces apoptosis in chronic myeloid leukemia (CML) K562 cells. Inhibits in vivo tyrosine phosphorylation of Gab2, CrkL and p210bcr/abl (IC50 values are 80, 80 and 170 nM respectively). Potently inhibits p210bcr/abl autophosphorylation in vitro (IC50 = 5 nM). Also potently inhibits c-Src and KIT (IC50 values are 0.8 and 50 nM, respectively). Induces autophagy and reduces neuroinflammation in animal models of Parkinson's disease.

许可信息

Sold for research purposes under agreement from Pfizer Inc.

技术数据 for PD 180970

分子量 429.27
公式 C21H15Cl2FN4O
储存 Store at +4°C
纯度 ≥98% (HPLC)
CAS Number 287204-45-9
PubChem ID 5311104
InChI Key SLCFEJAMCRLYRG-UHFFFAOYSA-N
Smiles CN(C(C(C4=C(Cl)C=CC=C4Cl)=C3)=O)C1=C3C=NC(NC2=CC(C)=C(F)C=C2)=N1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

按产品操作查看相关产品

查看全部 Abl Kinase Inhibitors

关键词: PD 180970, PD 180970 supplier, PD180970, Pfizer, Bcr-Abl, tyrosine, kinase, inhibitors, inhibits, c-Src, KIT, Abl, Kinase, Src, Kinases, Other, RTKs, Autophagy, 4965, Tocris Bioscience

1 篇 PD 180970 的引用文献

引用文献是使用了 Tocris 产品的出版物。 PD 180970 的部分引用包括:

Sn et al (2019) Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration. EBioMedicine 50 260 PMID: 31727601


PD 180970 的评论

目前没有该产品的评论。 Be the first to review PD 180970 and earn rewards!

Have you used PD 180970?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review